Guangzhou Wondfo Biotech Co.,Ltd (SHE:300482)

SHE:300482 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	306.67	828.69	840.3	1,163	996.15	1,408
Short-Term Investments	-	62.86	623.04	200.26	-	-
Trading Asset Securities	1,628	1,306	722.45	938.07	572.73	102.6
Cash & Short-Term Investments	1,935	2,198	2,186	2,301	1,569	1,511
Cash Growth	-11.30%	0.55%	-5.00%	46.66%	3.84%	54.09%
Accounts Receivable	1,392	1,130	599.87	540.97	501.78	269.93
Other Receivables	57.47	44.25	51.72	66.6	64.7	68.38
Receivables	1,450	1,174	651.59	607.57	566.48	338.31
Inventory	319.59	359.56	351.4	399.97	386.24	376.66
Other Current Assets	120.65	54.17	44.57	42	63.9	44.41
Total Current Assets	3,825	3,786	3,233	3,350	2,586	2,270
Property, Plant & Equipment	1,481	1,484	1,353	1,189	906.09	676.63
Long-Term Investments	1,388	1,391	709.48	1,284	971.42	1,025
Goodwill	111.42	111.42	111.42	115.37	42.51	48.39
Other Intangible Assets	225.34	205.51	194.52	203.71	208.11	180.19
Long-Term Deferred Tax Assets	76.75	76.18	57.47	53.86	42.77	24.45
Long-Term Deferred Charges	55.34	56.46	80.03	65.04	69.76	59.48
Other Long-Term Assets	19.55	44.59	32.83	39.41	29.66	21.33
Total Assets	7,183	7,155	5,772	6,301	4,856	4,306
Accounts Payable	237.41	288.37	130.46	320.08	399.99	299.51
Accrued Expenses	77.63	201.41	193.5	229.74	184.01	190.59
Short-Term Debt	0.04	14.85	4.26	208.42	19.14	101
Current Portion of Long-Term Debt	-	-	-	-	12.53	9.07
Current Portion of Leases	5.56	5.41	19.01	16.86	28.24	-
Current Income Taxes Payable	57.01	42.6	21.84	58.73	4.69	52.69
Current Unearned Revenue	63.13	77.1	72.88	236.31	80.55	97.68
Other Current Liabilities	220.76	191.73	42.29	70.91	62.4	42.9
Total Current Liabilities	661.55	821.46	484.23	1,141	791.54	793.45
Long-Term Debt	577.96	570.97	552.84	532.49	510.69	501.03
Long-Term Leases	12.71	14.33	27.69	11.19	10.42	0.78
Long-Term Unearned Revenue	45.44	47.94	37.21	23.1	9.4	8.11
Long-Term Deferred Tax Liabilities	44.67	49.66	55.12	55.75	29.7	9.1
Total Liabilities	1,342	1,504	1,157	1,764	1,352	1,312
Common Stock	481.42	481.42	444.52	444.51	444.95	342.57
Additional Paid-In Capital	1,458	1,458	765.52	775.53	787.01	866
Retained Earnings	3,996	3,807	3,433	3,166	2,101	1,637
Treasury Stock	-171.02	-171.02	-132.46	-157.3	-139.25	-127.56
Comprehensive Income & Other	-21.32	-21.29	5.9	115.39	159.18	123.98
Total Common Equity	5,743	5,554	4,516	4,344	3,353	2,842
Minority Interest	96.84	95.9	98.66	193.8	150.97	151.33
Shareholders' Equity	5,840	5,650	4,615	4,538	3,504	2,994
Total Liabilities & Equity	7,183	7,155	5,772	6,301	4,856	4,306
Total Debt	596.27	605.57	603.8	768.96	581.01	611.89
Net Cash (Debt)	1,338	1,592	1,582	1,532	987.87	899.02
Net Cash Growth	-14.41%	0.65%	3.27%	55.07%	9.88%	-3.83%
Net Cash Per Share	2.82	3.43	3.57	3.47	2.23	2.04
Filing Date Shares Outstanding	484.96	477.87	440.96	441.26	444.95	445.34
Total Common Shares Outstanding	484.96	477.87	440.96	441.26	444.95	445.34
Working Capital	3,163	2,964	2,749	2,209	1,794	1,477
Book Value Per Share	11.84	11.62	10.24	9.84	7.54	6.38
Tangible Book Value	5,407	5,237	4,210	4,025	3,102	2,614
Tangible Book Value Per Share	11.15	10.96	9.55	9.12	6.97	5.87
Buildings	-	1,007	530.37	447.3	436.03	202.5
Machinery	-	1,071	1,021	940.43	741.37	575.35
Construction In Progress	-	5.12	290.84	199.14	16.38	156.18

Source: S&P Global Market Intelligence. Standard template. Financial Sources.